"iDoctor – Medical Blog"

Publication year: 2009<br><b>Source:</b> The American Journal of Cardiology, Volume 104, Issue 5, Supplement 1, 7 September 2009, Pages 34C-38C<br>Patrick, Willis , Michele Doughty, Voeltz<br><br>Advances in antithrombotic and antiplatelet therapies have led to a reduction in ischemic event rates in percutaneous coronary intervention (PCI), acute coronary syndromes (ACS), and ST-segment elevation myocardial infarction (STEMI) but have generally resulted in an increased risk of hemorrhagic complications. In these settings, both baseline anemia and acute hemorrhage occur with relative frequency and are associated with increased morbidity and mortality. Although commonly treated with blood transfusion, this intervention may accentuate rat

This entry was posted on Thursday, August 20th, 2009 at 3:15 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.